United States Nuclear Medicine Market Insight
Published: 13 June 2026 | Report Format: Electronic (PDF)
United States Nuclear Medicine Market is expected to grow at a rate of 8.12% owing to the rising prevalence of cancer and cardiovascular diseases, increasing adoption of molecular imaging technologies.
United States Nuclear Medicine Market Insights & Forecasts to 2035
- The United States Nuclear Medicine Market size was estimated at around USD 8.9 Billion in 2025
- The market is projected to grow at a CAGR of around 8.12% from 2025 to 2035
- The market is expected to reach approximately USD 19.4 Billion by 2035
Notable Insights for the United States Nuclear Medicine Market
- Segmentation by Product Type indicates that Diagnostic Radiopharmaceuticals dominate the market with nearly 57% share in 2025, driven by extensive use in oncology, cardiology, neurology, and disease detection applications.
- Segmentation by Application shows that Oncology holds the largest share of around 49% in 2025, owing to the increasing use of PET imaging and targeted radiopharmaceutical therapies for cancer diagnosis and treatment.
- Segmentation by Imaging Technology indicates that PET (Positron Emission Tomography) systems lead the market with nearly 52% share in 2025, supported by their high diagnostic accuracy and expanding clinical applications.
- Increasing adoption of theranostic approaches combining diagnostics and targeted therapy is improving treatment precision and patient outcomes across multiple disease areas.
- Growing investments in radiopharmaceutical production, cyclotron facilities, and isotope supply chains are supporting market expansion and enhancing access to advanced nuclear medicine procedures.
Download the eBook (ToC)
Why Buy This Report
- Provides deep insights into trends such as radiopharmaceutical innovation, molecular imaging advancements, theranostics, and precision medicine applications.
- Offers strategic analysis of oncology diagnostics, radionuclide therapy developments, healthcare infrastructure investments, and regulatory advancements in the United States.
- Helps businesses identify investment opportunities, competitive strategies, and innovation trends across the nuclear medicine and molecular imaging ecosystem.
Competitive Analysis:
The report gives an idea about big companies in the United States Nuclear Medicine Market. These companies are known for their products, tech and how they compete. They look at things like how efficient their productsre what new charging tech they have how they price things and how they get their products to customers. Companies are putting money into making adapters with Gallium Nitride, USB-C chargers that can charge fast and power solutions that are good, for the environment. Recent developments include collaborations with smartphone manufacturers, expansion of fast-charging product lines, and advancements in ultra-compact adapter designs.
Top Companies in the United States Nuclear Medicine Market
• GE HealthCare Technologies Inc.
• Siemens Healthineers AG
• Cardinal Health, Inc.
• Curium Pharma
• Lantheus Holdings, Inc.
• Jubilant Radiopharma
• Bracco Imaging S.p.A.
• Novartis AG
• Bayer AG
• Telix Pharmaceuticals Limited
Recent Developments:
• In 2025, several radiopharmaceutical manufacturers expanded production capacity to address growing demand for PET imaging tracers and targeted radionuclide therapies.
• Leading healthcare companies accelerated investments in theranostic platforms that combine diagnostic imaging and personalized treatment approaches.
• Growing adoption of prostate cancer, neuroendocrine tumor, and oncology-focused radioligand therapies increased demand for advanced nuclear medicine products and services.
Market Segmentation:
United States Nuclear Medicine Market, By Product Type
• Diagnostic Radiopharmaceuticals
• Therapeutic Radiopharmaceuticals
• Nuclear Medicine Equipment
• Radioisotope Supply Services
United States Nuclear Medicine Market, By Imaging Technology
• Positron Emission Tomography (PET)
• Single Photon Emission Computed Tomography (SPECT)
• Hybrid PET/CT Systems
• Hybrid SPECT/CT Systems
United States Nuclear Medicine Market, By Application
• Oncology
• Cardiology
• Neurology
• Endocrinology
• Orthopedics
• Other Chronic Diseases
United States Nuclear Medicine Market, By End User
• Hospitals
• Diagnostic Imaging Centers
• Academic & Research Institutes
• Specialty Clinics
• Cancer Treatment Centers
Expert Views:
The market for nuclear medicine in the United States is expected to continue growing due to increasing demand for precision diagnostics and targeted therapeutic solutions. Nuclear medicine plays a crucial role in early disease detection, treatment planning, and personalized patient care, particularly in oncology and cardiology. Advances in radiopharmaceutical development, molecular imaging technologies, and theranostic approaches are enhancing diagnostic accuracy and treatment effectiveness. Companies are investing heavily in isotope production, imaging infrastructure, and innovative radioligand therapies to address rising healthcare needs. As precision medicine becomes more widely adopted, the United States Nuclear Medicine Market is expected to experience strong and sustained growth through 2035.
Author: Sanket and Pranali By Decisions Advisors and Consulting